Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C6G | ISIN: CA09076J2074 | Ticker-Symbol: 8MV0
Frankfurt
06.06.25 | 08:07
5,950 Euro
-0,83 % -0,050
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOHARVEST SCIENCES INC Chart 1 Jahr
5-Tage-Chart
BIOHARVEST SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,0006,15006.06.

Aktuelle News zur BIOHARVEST SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
MiBioHarvest Sciences Inc.: BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles142Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
21.05.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
21.05.BioHarvest enters fragrance market with new AI-assisted project3
21.05.BioHarvest steigt mit KI-unterstütztem Projekt in den Duftmarkt ein2
21.05.BioHarvest secures new CDMO contract to develop plant-based fragrance compound3
21.05.BioHarvest Sciences Inc.: BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound284Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
16.05.BioHarvest outlines path to $11M-$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline2
BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln
15.05.BioHarvest Sciences Inc.: BioHarvest Sciences Reports First Quarter 2025 Financial Results286Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
12.05.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer3
12.05.BioHarvest Sciences Inc.: BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company221Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
05.05.BioHarvest stock gains on new Buy rating, $15 target from Craig-Hallum4
01.05.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer2
01.05.BioHarvest Sciences Inc.: BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time223Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
08.04.H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target1
01.04.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
31.03.BioHarvest Sciences GAAP EPS of -$0.17 misses by $0.03, revenue of $7.3M beats by $0.06M2
31.03.BioHarvest Sciences Inc.: BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results377Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 MillionCDMO Division Secures Anchor Partnership...
► Artikel lesen
17.03.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
17.03.BioHarvest Sciences Inc.: BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time304Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1